RareResearch.AI
← Back to atlas

c.682_684del

In-frame indelI2Pathogenic/Likely pathogenicCytoplasmic · predicted
In-frame indel variant · indel site at position 228 · N-terminal cytoplasmic (intrinsically disordered) · WFS1 (Wolframin)

I2Single-residue deletion in a soluble domain — variable impact

Wild-type vs Modified Structure

Wild-type · full length
Wild-type wolframin · 890 aa — AlphaFold reference
Fullscreen ↗
Modified product
Modified product · c.682_684del — Cα-RMSD 0.79 Å vs WT (folded core)
Fullscreen ↗

Left: full-length wild-type wolframin (890 aa). Right: the ColabFold (AlphaFold2) prediction of the 1-aa in-frame deletion product — the affected region near residue 228 (N-terminal cytoplasmic (intrinsically disordered)) is highlighted in both panes. Backbone Cα-RMSD over the folded core is 0.79 Å.

Variant Assessment

Variant type
In-frame indel
Schema
I2
Single-residue deletion in a soluble domain — variable impact
Domain
N-terminal cytoplasmic (intrinsically disordered)
Backbone Cα-RMSD
0.79 Å
vs WT · folded core (n=122)

Modified-sequence structure resolved. The 1-aa in-frame deletion was modeled with ColabFold (AlphaFold2, full-MSA; mean pLDDT 70.4) and superposed on the wild-type AlphaFold model. Kabsch-superposed Cα-RMSD over high-confidence (WT pLDDT>70) residues N-terminal to the lesion; cross-pipeline, includes ~few-Å method baseline

Therapeutic Implication · I2

A single residue removed in N-terminal cytoplasmic (intrinsically disordered) (a soluble, non-membrane region) may be tolerated or may locally distort the domain. Worth pharmacological-chaperone exploration if AlphaFold predicts a near-native fold. Predicted structure pending (ColabFold).

Clinical Evidence

ClinVar classificationPathogenic/Likely pathogenic
Review status
Associated conditions
Population frequency (gnomAD v4)Absent from gnomAD v4
cDNA changec.682_684del
ClinVar variantc.682_684del
ClinVar accession
Last evaluated

Not observed in ~730k individuals — consistent with a rare allele (ACMG PM2_supporting).

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the c.682_684del card below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals matched to this I2 in-frame indel variant and its domain context.

Full Variant Card

c.682_684del — WFS1 Molecular Atlas Card

Variant type: In-frame indel Change: 1 residue(s) deleted in frame at position 228 Domain context: N-terminal cytoplasmic (intrinsically disordered)


Schema category: I2 — Single-residue deletion in a soluble domain — variable impact

A single residue removed in N-terminal cytoplasmic (intrinsically disordered) (a soluble, non-membrane region) may be tolerated or may locally distort the domain. Worth pharmacological-chaperone exploration if AlphaFold predicts a near-native fold. Predicted structure pending (ColabFold).


Structural prediction

  • Reading frame: preserved (in-frame) — no premature stop, NMD does not apply.
  • Affected domain: N-terminal cytoplasmic (intrinsically disordered)
  • Predicted modified structure: pending — AlphaFold/ColabFold prediction of the modified sequence and backbone-RMSD vs wild-type backfill here (Wave 2).

Clinical evidence

Not found in the cached WFS1 ClinVar set (_reference/WFS1_clinvar_variants.csv).


Card generated by wolfram-atlas-batch (in-frame indel pipeline) on 2026-06-08T02:42:06.254545Z. Schema: reference/card_schema_extension.md (I1–I3). WFS1: UniProt O76024, AlphaFold v6.